University of Illinois Chicago
Browse

The cyclic peptide ecumicin targeting clpC1 is active against Mycobacterium tuberculosis in vivo

Download (1.56 MB)
journal contribution
posted on 2022-04-13, 16:56 authored by Sang Hyun ChoSang Hyun Cho, W Gao, J Kim, JR Anderson, T Akopian, S Hong, Y Jin, O Kandror, I Lee, S Lee, JB McAlpine, S Mulugeta, S Sunogrot, Y Wang, S Yang, T Yoon, AL Goldberg, Guido PauliGuido Pauli, J Suh, Scott FranzblauScott Franzblau
No description supplied

History

Citation

Cho, S. H., Gao, W., Kim, J., Anderson, J. R., Akopian, T., Hong, S., Jin, Y., Kandror, O., Kim, J., Lee, I., Lee, S., McAlpine, J. B., Mulugeta, S., Sunogrot, S., Wang, Y., Yang, S., Yoon, T., Goldberg, A. L., Pauli, G. F.Franzblau, S. G. (n.d.). The cyclic peptide ecumicin targeting clpC1 is active against Mycobacterium tuberculosis in vivo. Antimicrobial Agents and Chemotherapy, 880-889.

Publisher

American Society for Microbiology

issn

0066-4804

Usage metrics

    Categories

    Keywords

    MicrobiologyMedical MicrobiologyPharmacology and Pharmaceutical SciencesMicrobiology

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC